Label: DAYAVITE- coenzyme q10, alpha-lipoic acid, ascorbic acid, beta-carotene, cholecalciferol, chromium, copper, d-alpha tocopheryl acid, folic acid, magnesium, manganese, methylcobalamin, molybdenum amino acid, niacinamide, potassium, pyridoxine, riboflavin, selenium, thiamine, zinc tablet, coated

OTHER INGREDIENTS: Croscarmellose Sodium, Film Coating (Polyvinyl Alcohol, Polyethylene Glycol, Titanium Dioxide, Talc, FD&C Red #40, FD&C Yellow #6), Stearic Acid, Calcium Carbonate, Pharmaceutical Glaze, Microcrystalline Cellulose, Magnesium Stearate, Mono-and Diglycerides, Silicon Dioxide.

DAYAVITE Tablets is an orally administered prescription vitamin formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced folate supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed.

DAYAVITE is a long, oblong, dark pink, clear-coated tablet, with debossed "A3” on one side.

CONTRAINDICATIONS
This product is contraindicated in patients with known hypersensitivity to any of the ingredients.

PRECAUTIONS
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

DAYAVITE Tablets should only be used under the direction and supervision of a licensed medical practitioner. Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications.

Folic acid supplementation may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations progress.

KEEP OUT OF REACH OF CHILDREN.

Pregnancy and Lactation:
DAYAVITE Tablets is not intended for use in pregnant or lactating patients.

ADVERSE REACTIONS
Allergic sensitizations have been reported following oral administration of folic acid. Consult your physician immediately if adverse side effects occur.

Usual adult dose is 1 tablet by mouth once daily or as prescribed by a licensed medical practitioner.

DAYAVITE Tablets are supplied as a long, oblong, dark pink, clear-coated tablet, with debossed "A3” on one side.
DAYAVITE Tablets is available as the following:
72287-0663-30*       30ct       bottle

Store at 20° to 25°C (68° to 77°F; excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]

Manufactured for:
Amella Pharma, LLC
E Brunswick, NJ 08816

Call your doctor for medical advice about side effects. You may report side effects to Amella Pharma, LLC at 1-844-385-0850.

Issued: 04/2021 AP11002v1

*Amella Pharma does not represent these product codes to be National Drug Codes (NDC). Product codes are formatted according to standard industry practice, to meet the formatting requirement by pedigree reporting and supply-chain control including pharmacies.

† This product is a prescription-folate with or without other dietary ingredients that – due to increased folate levels increased risk associated with masking of B12 deficiency (pernicious anemia) requires administration under the care of a licensed medical practitioner (61 FR 8760). The most appropriate way to ensure pedigree reporting consistent with these regulatory guidelines and safety monitoring is to dispense this product only by prescription (Rx). This is not an Orange Book product. This product may be administered only under a physician’s supervision and all prescriptions using this product shall be pursuant to state statutes as applicable. The ingredients, indication or claims of this product are not to be construed to be drug claims.

1. Federal Register Notice of August 2, 1973 (38 FR 20750)
2. Federal Register Notice of October 17, 1980 (45 FR 69043, 69044)
3. Federal Register Notice of March 5, 1996 (61 FR 8760)